Infection of human cells by dengue virus is modulated by different cell types and viral strains.

PubWeight™: 2.49‹?› | Rank: Top 2%

🔗 View Article (PMC 112311)

Published in J Virol on September 01, 2000

Authors

M S Diamond1, D Edgil, T G Roberts, B Lu, E Harris

Author Affiliations

1: Division of Infectious Diseases, School of Public Health, University of California, Berkeley, California 94720, USA.

Articles citing this

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol (2003) 4.87

Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev (2009) 3.61

Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe (2010) 3.33

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol (2007) 2.89

A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med (2003) 2.89

Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83

Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76

Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol (2006) 2.33

Infection and injury of neurons by West Nile encephalitis virus. J Virol (2003) 2.25

Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication. J Virol (2003) 2.14

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol (2003) 2.13

Immature dengue virus: a veiled pathogen? PLoS Pathog (2010) 2.04

Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03

American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03

A protective role for dengue virus-specific CD8+ T cells. J Immunol (2009) 1.98

Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog (2007) 1.97

Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol (2005) 1.97

DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80

Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol (2005) 1.78

Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol (2005) 1.75

Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J Clin Microbiol (2002) 1.71

Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology (2008) 1.60

Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol (2010) 1.58

STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog (2011) 1.54

TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog (2013) 1.53

Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol (2010) 1.45

Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42

RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol (2006) 1.38

Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J Immunol (2011) 1.35

Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J Virol (2006) 1.28

Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J Virol (2009) 1.27

ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26

Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol (2005) 1.26

Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25

Potential high-throughput assay for screening inhibitors of West Nile virus replication. J Virol (2003) 1.25

Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Cell Host Microbe (2016) 1.24

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio (2013) 1.21

Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20

Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem (2011) 1.16

Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol (2011) 1.15

A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response. MBio (2013) 1.13

A dengue receptor as possible genetic marker of vector competence in Aedes aegypti. BMC Microbiol (2008) 1.06

IFITM proteins restrict antibody-dependent enhancement of dengue virus infection. PLoS One (2012) 1.05

Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol (2014) 1.03

S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells. J Virol (2005) 1.03

Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One (2009) 1.02

Identification of novel small-molecule inhibitors of West Nile virus infection. J Virol (2007) 1.00

Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection. J Virol (2014) 0.99

Flavivirus RNA cap methyltransferase: structure, function, and inhibition. Front Biol (Beijing) (2010) 0.97

Highly divergent dengue virus type 1 genotype sets a new distance record. Sci Rep (2016) 0.97

A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology (2012) 0.94

A fusion-loop antibody enhances the infectious properties of immature flavivirus particles. J Virol (2011) 0.92

Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl Trop Dis (2011) 0.92

Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant. MBio (2015) 0.92

Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2. PLoS One (2012) 0.90

Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. J Med Virol (2008) 0.87

Role of microparticles in dengue virus infection and its impact on medical intervention strategies. Yale J Biol Med (2012) 0.87

Epidemiological Scenario of Dengue in Brazil. Biomed Res Int (2015) 0.86

Nucleotide substitutions in dengue virus serotypes from Asian and American countries: insights into intracodon recombination and purifying selection. BMC Microbiol (2013) 0.86

Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines. Virology (2011) 0.85

Additive protection by antioxidant and apoptosis-inhibiting effects on mosquito cells with dengue 2 virus infection. PLoS Negl Trop Dis (2012) 0.84

Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection. J Biol Chem (2015) 0.84

Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. J Virol (2016) 0.84

Patterns and causes of liver involvement in acute dengue infection. BMC Infect Dis (2016) 0.83

Distribution of fitness in populations of dengue viruses. PLoS One (2014) 0.83

Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro. PLoS Curr (2016) 0.82

Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus. Virol J (2012) 0.82

Interferon lambda inhibits dengue virus replication in epithelial cells. Virol J (2015) 0.79

A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol (2016) 0.78

Antibodies against immature virions are not a discriminating factor for dengue disease severity. PLoS Negl Trop Dis (2015) 0.77

Analogs of LDL Receptor Ligand Motifs in Dengue Envelope and Capsid Proteins as Potential Codes for Cell Entry. J Viruses (2016) 0.75

Induction of Osteopontin by Dengue Virus-3 Infection in THP-1 Cells: Inhibition of the Synthesis by Brefelamide and Its Derivative. Front Microbiol (2017) 0.75

Development and evaluation of an enzyme-linked immunosorbent assay for dengue capsid. Open Virol J (2012) 0.75

High-dimensional CyTOF analysis of dengue virus-infected human DCs reveals distinct viral signatures. JCI Insight (2017) 0.75

Articles cited by this

Pathogenesis of dengue: challenges to molecular biology. Science (1988) 14.73

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44

A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54

Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods (1974) 8.28

Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A (1994) 7.76

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med (1997) 6.57

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol (1984) 5.62

Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88

Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79

Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology (1990) 4.65

Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26

Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18

Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet (1999) 3.97

In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis (1979) 3.90

Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol (1998) 3.65

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61

Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis (1989) 3.53

Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol (1998) 3.51

Immunopathogenesis of Dengue hemorrhagic fever. Virology (1999) 3.16

Coupling between genome translation and replication in an RNA virus. Genes Dev (1994) 2.82

Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69

Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47

The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg (1977) 2.41

Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol (1999) 2.38

Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg (1999) 2.20

Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19

Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol (1998) 2.16

Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol (1998) 2.03

Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol (1988) 1.71

Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69

Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63

Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61

Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58

Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol (1999) 1.54

Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol (1984) 1.54

Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol (1991) 1.50

Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47

Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses (1990) 1.43

Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology (1999) 1.31

Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities. Virology (1998) 1.29

Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol (1990) 1.27

Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am J Trop Med Hyg (1999) 1.24

Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J Gen Virol (1996) 1.19

Production of mucopolysaccharides by normal and transformed cells. Proc Natl Acad Sci U S A (1973) 1.19

Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol (1992) 1.16

Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol (1992) 1.16

Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol (1999) 1.14

Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am J Trop Med Hyg (1991) 1.13

Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins. J Gen Virol (1998) 1.06

The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus. J Gen Virol (1994) 1.04

Surface sulfated mucopolysaccharides of primary and permanent mammalian cell lines. Biochem Biophys Res Commun (1978) 1.01

Lack of augmenting effect of interferon-gamma on dengue virus multiplication in human peripheral blood monocytes. J Med Virol (1995) 1.00

Endothelial cell monolayers as a model system to investigate dengue shock syndrome. J Virol Methods (1998) 0.99

Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection. J Gen Virol (1993) 0.97

Dengue virus infection of human T lymphocytes. Acta Virol (1997) 0.93

Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line. J Infect Dis (1998) 0.91

Dengue virus inhibits human hematopoietic progenitor growth in vitro. J Infect Dis (1997) 0.90

Articles by these authors

Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet (1990) 7.04

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31

Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell (1994) 4.53

Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet (1997) 4.48

Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47

Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature (1996) 4.41

A single amino acid can determine the DNA binding specificity of homeodomain proteins. Cell (1989) 4.05

Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell (1996) 3.91

Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84

The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73

Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol (1998) 3.65

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61

Obesity and inequities in health in the developing world. Int J Obes Relat Metab Disord (2004) 3.49

Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23

A new class of angiotensin-converting enzyme inhibitors. Nature (1980) 3.03

Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res (1999) 2.81

Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature (1995) 2.75

PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol (2001) 2.69

A conserved system for dorsal-ventral patterning in insects and vertebrates involving sog and chordin. Nature (1995) 2.58

Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature (1996) 2.54

Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell (1997) 2.44

The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev (1991) 2.35

The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci (2000) 2.28

Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci (1999) 2.26

A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24

Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg (1999) 2.20

Neurogenic amplification of immune complex inflammation. Science (1996) 2.05

Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet (1999) 2.04

BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development (2000) 2.02

The mouse Engrailed-1 gene and ventral limb patterning. Nature (1996) 1.98

Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903. HIV Med (2006) 1.97

Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. Ann Intern Med (2000) 1.94

The ultimate speed of magnetic switching in granular recording media. Nature (2004) 1.89

Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology (2001) 1.87

Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr Biol (1998) 1.83

Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med (1997) 1.83

PCR detection and identification of Leishmania parasites in clinical specimens in Ecuador: a comparison with classical diagnostic methods. J Parasitol (1999) 1.80

Simplified polymerase chain reaction detection of new world Leishmania in clinical specimens of cutaneous leishmaniasis. Am J Trop Med Hyg (1998) 1.76

Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant (2010) 1.74

The transmission of refractive errors within eskimo families. Am J Optom Arch Am Acad Optom (1969) 1.66

Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus. J Neurosci (1998) 1.63

PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation. Nat Neurosci (2001) 1.62

Effect of sterilization method and other modifications on the wear resistance of acetabular cups made of ultra-high molecular weight polyethylene. A hip-simulator study. J Bone Joint Surg Am (2000) 1.58

Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest (1998) 1.57

Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (2009) 1.54

Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene (2009) 1.54

Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol (2001) 1.51

Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest (1997) 1.51

A call for health policy education in the medical school curriculum. JAMA (1995) 1.46

Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience (2004) 1.46

A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J Neurosci Res (1993) 1.45

Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44

The homeodomain: a new face for the helix-turn-helix? Bioessays (1992) 1.42

Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ (2011) 1.42

Maternal and Infant Services: examination of access in a culturally diverse community. J Paediatr Child Health (2003) 1.42

Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci (1995) 1.41

Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation (2005) 1.40

Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J (1996) 1.39

Gamma irradiation: effects on biomechanical properties of human bone-patellar tendon-bone allografts. Am J Sports Med (1996) 1.38

Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol (2000) 1.37

Drosophila par-1 is required for oocyte differentiation and microtubule organization. Curr Biol (2001) 1.37

A role for Gbx2 in repression of Otx2 and positioning the mid/hindbrain organizer. Nature (1999) 1.37

Isolation of distinct small ribonucleoprotein particles containing the spliced leader and U2 RNAs of Trypanosoma brucei. J Biol Chem (1990) 1.37

Training senior house officers. BMJ (1997) 1.35

Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res (1999) 1.32

The reliability and validity of doctor-recorded morbidity data in active data collection systems. Scand J Prim Health Care (1998) 1.31

Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes (2000) 1.31

In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop Relat Res (1996) 1.29

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br Med J (1976) 1.28

The hypothermia of hypoglycemia. Studies with 2-deoxy-D-glucose in normal human subjects and mice. N Engl J Med (1972) 1.28

Population bottlenecks and patterns of human polymorphism. Mol Biol Evol (1999) 1.28

A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia (2009) 1.27

An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res (1992) 1.26

Inhaled benzo(a)pyrene impairs long-term potentiation in the F1 generation rat dentate gyrus. Cell Mol Biol (Noisy-le-grand) (2004) 1.26

Neurotrophin 3 potentiates neuronal activity and inhibits gamma-aminobutyratergic synaptic transmission in cortical neurons. Proc Natl Acad Sci U S A (1994) 1.24

Widespread atypical cutaneous Leishmaniasis caused by Leishmania (L.) Chagasi in Nicaragua. Am J Trop Med Hyg (1999) 1.23

Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem (2001) 1.23

Subacute infantile mountain sickness. J Pathol (1988) 1.22

Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol (1999) 1.21

GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci (2001) 1.20

Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry (2010) 1.20

Facial corticosteroid addictive dermatitis in Guiyang City, China. Clin Exp Dermatol (2009) 1.20

Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol (2003) 1.17

Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. Antimicrob Agents Chemother (2000) 1.16

Calcium-dependent transmitter secretion reconstituted in Xenopus oocytes: requirement for synaptophysin. Science (1992) 1.15

Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol (2002) 1.14

Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn Mem (1999) 1.14

Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells. Oncogene (2010) 1.14

MMPI diagnosis of black psychiatric patients. Am J Psychiatry (1979) 1.12

Molecular cloning and functional characterization of the Xenopus Ca(2+)-binding protein frequenin. Proc Natl Acad Sci U S A (1995) 1.11

Response of myocardial connective tissue to development of experimental hypertrophy. Am J Physiol (1969) 1.08

The WASp-like protein scar regulates macropinocytosis, phagocytosis and endosomal membrane flow in Dictyostelium. J Cell Sci (2001) 1.08

Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br (2007) 1.08

The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus. Oncogene (2013) 1.06

Accelerated structural maturation induced by synapsin I at developing neuromuscular synapses of Xenopus laevis. Eur J Neurosci (1995) 1.06

Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol (2000) 1.06